Your browser doesn't support javascript.
loading
Extreme Periodic Fever, Aphthous Stomatitis, Pharyngitis, Adenitis (PFAPA): a discrete group of patients.
Broide, Mor; Levinsky, Yoel; Tal, Rotem; Harel, Liora; Shoham, Shoval; Ahmad, Sabreen Abu; Butbul Aviel, Yonatan; Amarilyo, Gil.
Afiliación
  • Broide M; Department of Pediatrics A, Schneider Children's Medical Center of Israel, Petach Tikva, Israel. morbrd@gmail.com.
  • Levinsky Y; Pediatric Rheumatology Unit, Schneider Children's Medical Center of Israel, Petach Tikva, Israel.
  • Tal R; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Harel L; Pediatric Rheumatology Unit, Schneider Children's Medical Center of Israel, Petach Tikva, Israel.
  • Shoham S; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Ahmad SA; Pediatric Rheumatology Unit, Schneider Children's Medical Center of Israel, Petach Tikva, Israel.
  • Butbul Aviel Y; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Amarilyo G; Schneider Children's Medical Center of Israel, Petach Tikva, Israel.
Pediatr Rheumatol Online J ; 21(1): 93, 2023 Sep 01.
Article en En | MEDLINE | ID: mdl-37658370
ABSTRACT

OBJECTIVE:

Periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome is the most common periodic fever syndrome in children; by definition, episodes occur every 2 to 8 weeks. However, in a subset of our patients, we noticed a higher frequency of attacks, of less than 2 weeks, which we refer to as extreme PFAPA (ePFAPA). This group consisted of patients who were extreme upon presentation of PFAPA, and those who became extreme after initiation of abortive corticosteroid treatment. We aimed to characterize demographic and clinical features of ePFAPA, including the two groups, and to compare them to patients with non-extreme PFAPA (nPFAPA). STUDY

DESIGN:

The medical records of 365 patients with PFAPA who attended Schneider Children's Medical Center of Israel from March 2014 to April 2021 were reviewed. Patients with concomitant familial Mediterranean fever were excluded. Characteristics of the ePFAPA (including subgroups) and nPFAPA groups were compared using Wilcoxon rank sum, Pearson's chi-squared, and Fisher's exact tests.

RESULTS:

Forty-seven patients (12.9%) were identified as having ePFAPA. Among patients with ePFAPA, compared to patients with nPFAPA, the median (interquartile range) age at disease onset was earlier 1.5 years (0.7-2.5) vs. 2.5 years (1.5-4.0), P < 0.001; and diagnosis was younger 2.6 years (2.0-3.6) vs. 4.5 years (3.0-6.2), P < 0.001. A higher proportion of patients with ePFAPA than nPFAPA were treated with colchicine prophylaxis (53% vs. 19%, P < 0.001), but symptoms and signs during flares did not differ significantly between these groups. Demographic and clinical characteristics were similar between patients with ePFAPA from presentation of PFAPA (22, 47% of those with ePFAPA) and ePFAPA from after corticosteroid treatment.

CONCLUSION:

About half the patients categorized with ePFAPA syndrome already had extreme features upon presentation. Patients with ePFAPA compared to nPFAPA presented and were diagnosed at an earlier age.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fiebre Mediterránea Familiar / Estomatitis Aftosa / Faringitis / Linfadenopatía / Linfadenitis Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Child / Humans / Infant Idioma: En Revista: Pediatr Rheumatol Online J Año: 2023 Tipo del documento: Article País de afiliación: Israel

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fiebre Mediterránea Familiar / Estomatitis Aftosa / Faringitis / Linfadenopatía / Linfadenitis Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Child / Humans / Infant Idioma: En Revista: Pediatr Rheumatol Online J Año: 2023 Tipo del documento: Article País de afiliación: Israel